Th17-to-Tfh plasticity during periodontitis limits disease pathology
Journal of Experimental Medicine · 05.08.2024 · 221 (8)
DOI: 10.1084/jem.20232015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 31.05.2024. Verfasst von Flora A McClure und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The Univer…. Hauptthemen laut MEDLINE: Th17 Cells, Periodontitis, Cell Plasticity, Interleukin-17. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Royal Society, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Th17 cell plasticity is crucial for development of autoinflammatory disease pathology. Periodontitis is a prevalent inflammatory disease where Th17 cells mediate key pathological roles, yet whether they exhibit any functional plasticity remains unexplored. We found that during periodontitis, gingival IL-17 fate-mapped T cells still predominantly produce IL-17A, with little diversification of cytokine production. However, plasticity of IL-17 fate-mapped cells did occur during periodontitis, but in the gingiva draining lymph node. Here, some Th17 cells acquired features of Tfh cells, a functional plasticity that was dependent on IL-6. Notably, Th17-to-Tfh diversification was important to limit periodontitis pathology. Preventing Th17-to-Tfh plasticity resulted in elevated periodontal bone loss that was not simply due to increased proportions of conventional Th17 cells. Instead, loss of Th17-to-Tfh cells resulted in reduced IgG levels within the oral cavity and a failure to restrict the biomass of the oral commensal community. Thus, our data identify a novel protective function for a subset of otherwise pathogenic Th17 cells during periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester , Manchester, UK.
- Cellular and Molecular Medicine, University of Bristol , Bristol, UK.
ORCID-Profile: Flora A McClure, Kelly Wemyss, Joshua R Cox, Hayley M Bridgeman, Ian E Prise, James I King, Shafqat Jaigirdar, Annie Whelan, Gareth W Jones, John R Grainger, Matthew R Hepworth, Joanne E Konkel
Förderung
- Wellcome Trust
- Royal Society
- Biotechnology and Biological Sciences Research Council
- University of Manchester
- Lister Institute for Preventative Medicine
- Kennedy Trust for Rheumatology Research
- Versus Arthritis
Zitieren
APA
McClure, F. A., Wemyss, K., Cox, J. R., Bridgeman, H. M., Prise, I. E., King, J. I., Jaigirdar, S., Whelan, A., Jones, G. W., Grainger, J. R., Hepworth, M. R., & Konkel, J. E. (2024). Th17-to-Tfh plasticity during periodontitis limits disease pathology. Journal of Experimental Medicine, 221(8). https://doi.org/10.1084/jem.20232015
Vancouver
McClure FA, Wemyss K, Cox JR, Bridgeman HM, Prise IE, King JI, et al. Th17-to-Tfh plasticity during periodontitis limits disease pathology. Journal of Experimental Medicine. 2024;221(8). doi:10.1084/jem.20232015
BibTeX
@article{McClure2024,
author = {McClure, Flora A and Wemyss, Kelly and Cox, Joshua R and Bridgeman, Hayley M and Prise, Ian E and King, James I and Jaigirdar, Shafqat and Whelan, Annie and Jones, Gareth W and Grainger, John R and Hepworth, Matthew R and Konkel, Joanne E},
title = {Th17-to-Tfh plasticity during periodontitis limits disease pathology},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {8},
doi = {10.1084/jem.20232015}
}
EUVIMED